Hub88 adds Popiplay portfolio to platform

Date:

Hub88 has added content from creative iGaming studio Popiplay to its leading aggregation platform, providing operators with an extensive collection of premium slots.

The partnership will see Popiplay, founded in 2022, significantly expand its global reach through Hub88’s large operator network.

Popiplay slots are created with a goal to provide unique and highly rewarding online gambling experiences, with a player-first, streamer-focused, and mobile-friendly approach. Best-performing titles include Moneyfest, Master of Lightning and Dogmasons MegaWoof,.

The collaboration will also see Popiplay strategically leverage Hub88’s advanced analytics and player insights to refine its future games, ensuring they remain captivating and engaging for players worldwide.

Popiplay is the latest in a string of new studios that have joined Hub88’s aggregation platform which now features 12,000+ titles from both established and emerging iGaming providers.

Jess Inglott, Head of Supplier Relations at Hub88, said:

Popiplay aims to revolutionise the iGaming scene, providing players with a superior gaming choice, and we are thrilled to welcome them onto our platform. Their commitment to innovation and providing premium entertainment perfectly align with ours, and we are confident that Popiplay’s content will be a hit with operators and players alike.

Denis Ristic, CEO at Popiplay, said:

At Popiplay, our mission has always been to deliver exceptional gaming experiences. The partnership with Hub88 is a testament to our dedication to strategic growth and player satisfaction. We believe that Hub88’s expertise and extensive network will be instrumental in achieving our growth objectives. We are enthusiastic about the potential of this partnership and look forward to a successful journey together.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

Triptans Trump Newer, More Expensive Meds for Acute Migraine

Four triptans are more effective for acute migraine than...

Five Steps to Improve Colonoscopy Performance

As quality indicators and benchmarks for colonoscopy increase in...

Adalimumab Tops Cyclosporine in Preventing Uveitis Relapse

TOPLINE:Adalimumab combined with corticosteroids was more advantageous than cyclosporine...

Cancer Risk: Are Pesticides the New Smoking?

Pesticides have transformed modern agriculture by boosting production yields...